Oric Pharmaceuticals, Inc. ORIC Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s shares (diluted)?
- Oric Pharmaceuticals, Inc. (ORIC) reported shares (diluted) of 105.5M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Oric Pharmaceuticals, Inc.'s shares (diluted) increased by 48.5% year-over-year, from 71M to 105.5M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s shares (diluted) has grown at a 22.3% compound annual growth rate (CAGR), from 150.3M to 335.9M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.